JP2024511955A5 - - Google Patents
Info
- Publication number
- JP2024511955A5 JP2024511955A5 JP2023555748A JP2023555748A JP2024511955A5 JP 2024511955 A5 JP2024511955 A5 JP 2024511955A5 JP 2023555748 A JP2023555748 A JP 2023555748A JP 2023555748 A JP2023555748 A JP 2023555748A JP 2024511955 A5 JP2024511955 A5 JP 2024511955A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- pharmaceutical composition
- composition according
- peptide
- terminus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163160705P | 2021-03-12 | 2021-03-12 | |
| US63/160,705 | 2021-03-12 | ||
| US202163194039P | 2021-05-27 | 2021-05-27 | |
| US63/194,039 | 2021-05-27 | ||
| PCT/US2022/020061 WO2022192749A2 (en) | 2021-03-12 | 2022-03-11 | Methods of treating duchenne muscular dystrophy using peptide-oligonucleotide conjugates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024511955A JP2024511955A (ja) | 2024-03-18 |
| JP2024511955A5 true JP2024511955A5 (https=) | 2025-04-03 |
Family
ID=83228540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023555748A Pending JP2024511955A (ja) | 2021-03-12 | 2022-03-11 | ペプチド－オリゴヌクレオチド複合体を用いるデュシェンヌ型筋ジストロフィーの治療法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240200062A1 (https=) |
| EP (1) | EP4304628A4 (https=) |
| JP (1) | JP2024511955A (https=) |
| WO (1) | WO2022192749A2 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20200131231A1 (en) | 2017-02-17 | 2020-04-30 | Oxford University Innovation Limited | Cell penetrating peptides |
| GB201812980D0 (en) | 2018-08-09 | 2018-09-26 | Univ Oxford Innovation Ltd | Cell-penetrating peptides |
| GB201812972D0 (en) | 2018-08-09 | 2018-09-26 | Univ Oxford Innovation Ltd | Cell-penetrating peptides |
| US12465646B2 (en) | 2018-12-07 | 2025-11-11 | Oxford University Innovation Limited | Linkers |
| EP4702143A2 (en) | 2023-04-24 | 2026-03-04 | BioMarin Pharmaceutical Inc. | Compositions and methods for treating stxbp1 disorders |
| WO2025264554A1 (en) | 2024-06-17 | 2025-12-26 | Pepgen Inc. | Antisense oligonucleotide conjugates targeting peripheral myelin protein 22 (pmp22) and methods of use thereof |
| WO2026080471A2 (en) | 2024-10-07 | 2026-04-16 | Flagship Pioneering Innovations Vi, Llc | Compositions of trem conjugates and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103998458B (zh) * | 2011-08-30 | 2018-10-09 | 医学研究理事会 | 具有中央疏水域的细胞穿透肽 |
| WO2015161255A1 (en) * | 2014-04-18 | 2015-10-22 | Board Of Regents Of The Nevada System Of Higher Education, On Behalf Of The University Of Nevada, Reno | Methods for enhancing or decreasing the levels of mir124 and mir29 in subjects with muscular dystrophy |
| EP3858993A1 (en) * | 2015-10-09 | 2021-08-04 | Sarepta Therapeutics, Inc. | Compositions and methods for treating duchenne muscular dystrophy and related disorders |
| GB201812972D0 (en) * | 2018-08-09 | 2018-09-26 | Univ Oxford Innovation Ltd | Cell-penetrating peptides |
| US12465646B2 (en) * | 2018-12-07 | 2025-11-11 | Oxford University Innovation Limited | Linkers |
| WO2022171972A1 (en) * | 2021-02-12 | 2022-08-18 | Oxford University Innovation Limited | Cell-penetrating peptide conjugates and methods of their use |
-
2022
- 2022-03-11 WO PCT/US2022/020061 patent/WO2022192749A2/en not_active Ceased
- 2022-03-11 JP JP2023555748A patent/JP2024511955A/ja active Pending
- 2022-03-11 US US18/281,680 patent/US20240200062A1/en active Pending
- 2022-03-11 EP EP22768142.6A patent/EP4304628A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024511955A5 (https=) | ||
| JP2024506099A5 (https=) | ||
| JP2024511954A5 (https=) | ||
| US6559279B1 (en) | Process for preparing peptide derivatized oligomeric compounds | |
| CN103998458B (zh) | 具有中央疏水域的细胞穿透肽 | |
| US12583889B2 (en) | Cell penetrating peptides | |
| US20260091120A1 (en) | Cell-penetrating peptides | |
| JP7269968B2 (ja) | ペプチド担体上の多重オリゴヌクレオチド部分 | |
| JP2025063139A (ja) | リンカー | |
| JP2024518068A5 (https=) | ||
| CN107074911B (zh) | 肽核酸单体和低聚体 | |
| WO1995006056A1 (en) | Bridged polycationic polymer-oligonucleotide conjugates and methods for preparing same | |
| BR112019027880A2 (pt) | molécula de penetração de célula de carregamento de fármaco, métodos para facilitar a absorção de um composto biologicamente ativo, para melhorar a biodisponibilidade de um fármaco ou composto biologicamente ativo, para introduzir um fármaco ou composto biologicamente ativo em um sítio, para tratar um indivíduo, e, composição | |
| WO1995024222A1 (en) | Cyclic polycationic polymer-oligonucleotide conjugates and methods for preparing same | |
| US20040072743A1 (en) | Pharmaceutical composition of modified pna molecules | |
| JP2025513521A (ja) | 治療薬を送達するための環状ペプチド | |
| JP2024532464A5 (https=) | ||
| JP2002539077A (ja) | 二本鎖核酸とのヌクレオチド塩基対−特異的相互作用を受ける環状化合物に関する組成物および方法 | |
| RU2023123089A (ru) | Проникающие в клетки пептидные конъюгаты | |
| EP4612162A1 (en) | Shortened cell-penetrating peptides | |
| WO1999065512A1 (fr) | Compositions medicinales contenant des peptides apparentes au facteur de croissance des fibroblastes | |
| RU2021119028A (ru) | Линкеры | |
| WO2002053574A2 (en) | Modified pna molecules | |
| HK1235073A1 (en) | Peptide-nucleic acid-monomers and -oligomers |